{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:05:39Z","timestamp":1794492339560,"version":"4.9.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"23","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Patient-Centered Clinical Research Coordinating Center","id":[{"id":"https:\/\/ror.org\/00fzvsb30","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Health & Welfare","award":["RS-2021-KH119931"],"award-info":[{"award-number":["RS-2021-KH119931"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government","award":["IRIS RS-2024-00340590"],"award-info":[{"award-number":["IRIS RS-2024-00340590"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>A recent European trial found that in frail elderly patients with atrial fibrillation (AF), switching from well-managed warfarin to direct oral anticoagulants (DOACs) was associated with higher bleeding risk. This study aimed to evaluate the safety and effectiveness of switching from warfarin to DOACs in frail elderly Asian AF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Korean national claims database was used to identify AF patients aged \u226575 years who were prescribed warfarin between January 2013 and August 2015, had Hospital Frailty Risk Score \u2265 5, and experienced no major bleeding or thromboembolic events during this period. To evaluate the effect of switching from warfarin to a DOAC, a time-varying approach based on anticoagulant exposure was applied. The primary outcome was major bleeding. Secondary outcomes included thromboembolic events, net clinical outcome (NCO; composite of major bleeding and thromboembolic events), and all-cause death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 12 461 patients, 9112 patients remained on warfarin, whereas 3349 switched to DOACs at least once. During a total follow-up of 11 842 person-years, DOAC treatment was associated with higher risks of major bleeding (hazard ratio 1.36, 95% confidence interval 1.01\u20131.81), thromboembolic events (1.61, 1.30\u20132.00), NCO (1.58, 1.29\u20131.94), and all-cause death (1.20, 1.02\u20131.42). In various subgroup analyses, DOAC treatment tended to show higher risks of all outcomes compared with warfarin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In frail elderly Asian AF patients stably maintained on warfarin, switching to DOACs was associated with higher risks of adverse clinical events, suggesting the need for careful consideration before routine switching.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaf999","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:38:01Z","timestamp":1763645881000},"page":"2937-2947","source":"Crossref","is-referenced-by-count":14,"title":["Switching from warfarin to direct oral anticoagulants in frail elderly Asian patients with atrial fibrillation: a Korean nationwide study"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-5015","authenticated-orcid":false,"given":"So-Ryoung","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9296-7345","authenticated-orcid":false,"given":"Young-Hae","family":"Go","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0411-6372","authenticated-orcid":false,"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Won","family":"Rha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ha","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-640X","authenticated-orcid":false,"given":"JungMin","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-6130","authenticated-orcid":false,"given":"Kyung-Yeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-0378","authenticated-orcid":false,"given":"Hyo-Jeong","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-6855","authenticated-orcid":false,"given":"Soonil","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1022-3553","authenticated-orcid":false,"given":"Bongseong","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myoung-jin","family":"Jang","sequence":"additional","affiliation":[{"name":"Medical Research Collaborating Center, Seoul National University Hospital , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-1263","authenticated-orcid":false,"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2504-9615","authenticated-orcid":false,"given":"Seil","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital , 101 Daehak-ro, Jongno-gu, Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul ,","place":["Republic of Korea"]},{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Chest & Heart Hospital , Liverpool ,","place":["United Kingdom"]},{"name":"Department of Clinical Medicine, Aalborg University , Aalborg ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"2026061519575304500_ehaf999-B1","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026061519575304500_ehaf999-B2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/cir.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"2026061519575304500_ehaf999-B3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/s0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2026061519575304500_ehaf999-B4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.7326\/m22-0511","article-title":"Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population-based cohort study","volume":"175","author":"Lau","year":"2022","journal-title":"Ann Intern Med"},{"key":"2026061519575304500_ehaf999-B5","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1161\/strokeaha.118.020232","article-title":"Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients","volume":"49","author":"Lip","year":"2018","journal-title":"Stroke"},{"key":"2026061519575304500_ehaf999-B6","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1161\/strokeaha.120.033338","article-title":"Comparing warfarin and 4 direct oral anticoagulants for the risk of dementia in patients with atrial fibrillation","volume":"52","author":"Lee","year":"2021","journal-title":"Stroke"},{"key":"2026061519575304500_ehaf999-B7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","article-title":"Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation","volume":"50","author":"Shen","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026061519575304500_ehaf999-B8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/s0140-6736(10)61194-4","article-title":"Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial","volume":"376","author":"Wallentin","year":"2010","journal-title":"Lancet"},{"key":"2026061519575304500_ehaf999-B9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3988\/jcn.2017.13.3.273","article-title":"Quality of anticoagulation with warfarin in Korean patients with atrial fibrillation and prior stroke: a multicenter retrospective observational study","volume":"13","author":"Hong","year":"2017","journal-title":"J Clin Neurol"},{"key":"2026061519575304500_ehaf999-B10","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1161\/strokeaha.115.009947","article-title":"Non-vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis","volume":"46","author":"Wang","year":"2015","journal-title":"Stroke"},{"key":"2026061519575304500_ehaf999-B11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jacc.2018.05.066","article-title":"Edoxaban in Asian patients with atrial fibrillation: effectiveness and safety","volume":"72","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026061519575304500_ehaf999-B12","doi-asserted-by":"publisher","first-page":"e005894","DOI":"10.1161\/circoutcomes.119.005894","article-title":"Effectiveness and safety of direct oral anticoagulants in relation to temporal changes in their use","volume":"13","author":"Lee","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026061519575304500_ehaf999-B13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/circulationaha.123.066485","article-title":"Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"key":"2026061519575304500_ehaf999-B14","doi-asserted-by":"publisher","first-page":"101652","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients","volume":"79","author":"Proietti","year":"2022","journal-title":"Ageing Res Rev"},{"key":"2026061519575304500_ehaf999-B15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"2026061519575304500_ehaf999-B16","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/a-2269-1123","article-title":"Racial differences in bleeding risk: an ecological epidemiological study comparing Korea and United Kingdom subjects","volume":"124","author":"Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"2026061519575304500_ehaf999-B17","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jacc.2018.11.051","article-title":"Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and low body weight","volume":"73","author":"Lee","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026061519575304500_ehaf999-B18","doi-asserted-by":"publisher","first-page":"754","DOI":"10.4070\/kcj.2020.0171","article-title":"Cardiovascular research using the Korean National Health Information Database","volume":"50","author":"Choi","year":"2020","journal-title":"Korean Circ J"},{"key":"2026061519575304500_ehaf999-B19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","article-title":"Data resource profile: the national health information database of the National Health Insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2026061519575304500_ehaf999-B20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/joa3.12364","article-title":"Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: a nationwide cohort study","volume":"36","author":"Yang","year":"2020","journal-title":"J Arrhythm"},{"key":"2026061519575304500_ehaf999-B21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/STROKEAHA.121.036757","article-title":"Effectiveness and safety of anticoagulation therapy in frail patients with atrial fibrillation","volume":"53","author":"Kim","year":"2022","journal-title":"Stroke"},{"key":"2026061519575304500_ehaf999-B22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.31083\/j.rcm2502052","article-title":"All-cause death and major adverse events in atrial fibrillation with frailty: observations from the Korea National Health Insurance Service Data","volume":"25","author":"Park","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"2026061519575304500_ehaf999-B23","doi-asserted-by":"publisher","first-page":"1050744","DOI":"10.3389\/fcvm.2022.1050744","article-title":"Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: a nationwide cohort study","volume":"9","author":"Yu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026061519575304500_ehaf999-B24","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"2026061519575304500_ehaf999-B25","doi-asserted-by":"publisher","first-page":"afad096","DOI":"10.1093\/ageing\/afad096","article-title":"A comparison of three approaches to measuring frailty to determine adverse health outcomes in critically ill patients","volume":"52","author":"Hao","year":"2023","journal-title":"Age Ageing"},{"key":"2026061519575304500_ehaf999-B26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1161\/STROKEAHA.122.041891","article-title":"Higher hospital frailty risk score is associated with increased risk of stroke: observational and genetic analyses","volume":"54","author":"Renedo","year":"2023","journal-title":"Stroke"},{"key":"2026061519575304500_ehaf999-B27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jclinepi.2003.12.008","article-title":"Time-dependent bias was common in survival analyses published in leading clinical journals","volume":"57","author":"van Walraven","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"2026061519575304500_ehaf999-B28","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1097\/CCM.0b013e3181b7fbbb","article-title":"Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies","volume":"37","author":"Shintani","year":"2009","journal-title":"Crit Care Med"},{"key":"2026061519575304500_ehaf999-B29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2026061519575304500_ehaf999-B30","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2026061519575304500_ehaf999-B31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2016.04.054","article-title":"Statins in familial hypercholesterolemia: consequences for coronary artery disease and all-cause mortality","volume":"68","author":"Besseling","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026061519575304500_ehaf999-B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"2026061519575304500_ehaf999-B33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2307\/2531094","article-title":"The analysis of rates using Poisson regression models","volume":"39","author":"Frome","year":"1983","journal-title":"Biometrics"},{"key":"2026061519575304500_ehaf999-B34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2307\/1402659","article-title":"Analysis of survival data under the proportional hazards model","volume":"43","author":"Breslow","year":"1975","journal-title":"Int Stat Rev"},{"key":"2026061519575304500_ehaf999-B35","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2307\/2670170","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2026061519575304500_ehaf999-B36","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/circulationaha.113.005451","article-title":"Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY atrial fibrillation registry","volume":"129","author":"Oldgren","year":"2014","journal-title":"Circulation"},{"key":"2026061519575304500_ehaf999-B37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/circulationaha.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"2026061519575304500_ehaf999-B38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"key":"2026061519575304500_ehaf999-B39","doi-asserted-by":"publisher","first-page":"f20","DOI":"10.1093\/ehjcvp\/pvz073","article-title":"Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients","volume":"7","author":"Silverio","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026061519575304500_ehaf999-B40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ahj.2020.08.006","article-title":"Non-vitamin K antagonist oral anticoagulants in very elderly east Asians with atrial fibrillation: a nationwide population-based study","volume":"229","author":"Kwon","year":"2020","journal-title":"Am Heart J"},{"key":"2026061519575304500_ehaf999-B41","doi-asserted-by":"publisher","first-page":"euad120","DOI":"10.1093\/europace\/euad120","article-title":"Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study","volume":"25","author":"Liu","year":"2023","journal-title":"Europace"},{"key":"2026061519575304500_ehaf999-B42","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.112.142158","article-title":"Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation","volume":"127","author":"Wallentin","year":"2013","journal-title":"Circulation"},{"key":"2026061519575304500_ehaf999-B43","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"2026061519575304500_ehaf999-B44","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJMoa1904143","article-title":"Antithrombotic therapy for atrial fibrillation with stable coronary disease","volume":"381","author":"Yasuda","year":"2019","journal-title":"N Engl J Med"},{"key":"2026061519575304500_ehaf999-B45","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026061519575304500_ehaf999-B46","doi-asserted-by":"publisher","first-page":"1756284821997352","DOI":"10.1177\/1756284821997352","article-title":"Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients","volume":"14","author":"Deitelzweig","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"2026061519575304500_ehaf999-B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.117.031658","article-title":"Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study","volume":"138","author":"Chao","year":"2018","journal-title":"Circulation"},{"key":"2026061519575304500_ehaf999-B48","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.hrthm.2021.02.018","article-title":"Oral anticoagulants in extremely-high-risk, very elderly (&gt;90 years) patients with atrial fibrillation","volume":"18","author":"Chao","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026061519575304500_ehaf999-B49","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-dose edoxaban in very elderly patients with atrial fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N Engl J Med"},{"key":"2026061519575304500_ehaf999-B50","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1182\/bloodadvances.2020002335","article-title":"Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure","volume":"4","author":"Shaw","year":"2020","journal-title":"Blood Adv"},{"key":"2026061519575304500_ehaf999-B51","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40262-014-0228-0","article-title":"Effects of age and sex on the single-dose pharmacokinetics and pharmacodynamics of apixaban","volume":"54","author":"Frost","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"2026061519575304500_ehaf999-B52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/00003088-200847010-00005","article-title":"Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects","volume":"47","author":"Stangier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"2026061519575304500_ehaf999-B53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00003088-200847030-00006","article-title":"Population pharmacokinetics and pharmacodynamics of rivaroxaban\u2013an oral, direct factor Xa inhibitor\u2013in patients undergoing major orthopaedic surgery","volume":"47","author":"Mueck","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"2026061519575304500_ehaf999-B54","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.3346\/jkms.2018.33.e323","article-title":"Quality of anticoagulation and treatment satisfaction in patients with non-valvular atrial fibrillation treated with vitamin K antagonist: result from the KORean Atrial Fibrillation Investigation II","volume":"33","author":"Oh","year":"2018","journal-title":"J Korean Med Sci"},{"key":"2026061519575304500_ehaf999-B55","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42444-019-0005-0","article-title":"Validation of diagnostic codes of major clinical outcomes in a National Health Insurance database","volume":"20","author":"Park","year":"2019","journal-title":"Int J Arrhythmia"},{"key":"2026061519575304500_ehaf999-B56","doi-asserted-by":"publisher","first-page":"i3189","DOI":"10.1136\/bmj.i3189","article-title":"Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study","volume":"353","author":"Larsen","year":"2016","journal-title":"BMJ"},{"key":"2026061519575304500_ehaf999-B57","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.hrthm.2020.07.022","article-title":"Off-label dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation","volume":"17","author":"Chan","year":"2020","journal-title":"Heart Rhythm"},{"key":"2026061519575304500_ehaf999-B58","doi-asserted-by":"publisher","first-page":"e014177","DOI":"10.1161\/JAHA.119.014177","article-title":"Label adherence of direct oral anticoagulants dosing and clinical outcomes in patients with atrial fibrillation","volume":"9","author":"Yu","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2026061519575304500_ehaf999-B59","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3349\/ymj.2019.60.3.277","article-title":"Label adherence for non-vitamin K antagonist oral anticoagulants in a prospective cohort of Asian patients with atrial fibrillation","volume":"60","author":"Lee","year":"2019","journal-title":"Yonsei Med J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/23\/2937\/67158181\/ehaf999.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/23\/2937\/67158181\/ehaf999.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:57:59Z","timestamp":1781567879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/23\/2937\/8501363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":59,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2026,2,27]]},"published-print":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf999","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,14]]},"published":{"date-parts":[[2026,2,27]]}}}